GPX4 and gastric cancer: CA increases cisplatin sensitivity in GC by regulating Gpx4-dependent ferroptosis, indicating its therapeutic potential in augmenting cisplatin efficacy and establishing Gpx4 as a promising molecular target for GC treatment.